Medicine and Dentistry
Atopic Dermatitis
85%
Systematic Review
72%
Topical Corticosteroid
59%
Lichen Sclerosus
58%
Capillary Hemangioma
58%
Congenital Melanocytic Nevus
46%
COVID-19
46%
Propranolol
36%
Atenolol
36%
Skin Manifestation
36%
Meta-Analysis
35%
Quality of Life
34%
Mastocytosis
28%
Prevalence
27%
Netherton Syndrome
26%
Primary Health Care
24%
Magnetic Resonance Imaging
23%
Systemic Therapy
23%
Dupilumab
23%
Mast Cell
21%
Pediatrics
20%
Melanoma
18%
Beta Adrenergic Receptor Blocking Agent
18%
Eczema
17%
Cross Sectional Study
17%
Parental Stress
15%
Urticaria Pigmentosa
14%
Neurologic Disease
14%
Diseases
13%
Child Parent Relation
13%
Randomized Controlled Trial
13%
Histopathology
13%
Cohort Analysis
13%
General Practitioner
12%
Cyclosporine
12%
Palate
11%
Cleft Lip
11%
Differential Diagnosis
11%
Erythroderma
11%
Skin Defect
11%
Open-Label Trial
11%
Cell Count
11%
Antiinfective Agent
11%
Pediatric Dermatology
11%
Population Research
11%
Sturge-Weber Syndrome
11%
Prognostic Factor
11%
Ixekizumab
11%
Skin Tumor
11%
Alopecia Areata
11%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
82%
Dupilumab
46%
Topical Corticosteroid
38%
Skin Manifestation
36%
SARS Coronavirus
35%
Systemic Treatment
25%
Ciclosporin
24%
Capillary Hemangioma
23%
Netherton Disease
23%
Eczema
21%
Methotrexate
21%
Coronavirinae
17%
Respiratory Distress
17%
Erythema Multiforme
17%
Infection
17%
Pandemic
17%
Chilblain
17%
Mucocutaneous Lymph Node Syndrome
17%
Syndrome
17%
Urticaria
17%
Beta Adrenergic Receptor Blocking Agent
16%
Propranolol
13%
Atenolol
13%
Antiinfective Agent
11%
Pigmented Nevus
11%
Anakinra
11%
Ixekizumab
11%
Neurologic Disease
11%
Immunoglobulin E
11%
Adverse Event
7%
Chitosan
6%
Staphylococcus Aureus
6%
Physical Disease by Body Function
6%
Biological Product
6%
Immunology and Microbiology
Atopic Dermatitis
100%
Eczema
41%
Staphylococcus Aureus
30%
Immunoglobulin E
26%
Dupilumab
26%
Biological Product
23%
Gene Mutation
23%
Nose
23%
Asthma
21%
Immunodeficiency
18%
Primary Immunodeficiency
14%
Prevalence
13%
Haploinsufficiency
11%
Staphylococcus Protein A
11%
Mastocytosis
11%
Mast Cell
11%
Bacterial Colonization
11%
Ixekizumab
11%
Cell Count
11%
Magnetic Resonance Imaging
11%
Intravenous Immunoglobulin
11%
Anakinra
11%
Peanut Allergy
11%
Immune Response
11%
T Cell
11%
Immunoglobulin
11%
Microbiome
11%
Choroid Plexus
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Ciclosporin
9%
Combined Immunodeficiencies
8%
Prednisolone
7%
Allergic Rhinitis
7%
Food Allergy
6%
Capillary
5%